You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

List of Excipients in API MAVORIXAFOR

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing MAVORIXAFOR

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
X4 Pharmaceuticals Inc	XOLREMDI	mavorixafor	83296-100	CELLULOSE, MICROCRYSTALLINE	2031-04-26
X4 Pharmaceuticals Inc	XOLREMDI	mavorixafor	83296-100	CROSCARMELLOSE SODIUM	2031-04-26
X4 Pharmaceuticals Inc	XOLREMDI	mavorixafor	83296-100	DIBASIC CALCIUM PHOSPHATE DIHYDRATE	2031-04-26
X4 Pharmaceuticals Inc	XOLREMDI	mavorixafor	83296-100	SILICON DIOXIDE	2031-04-26
X4 Pharmaceuticals Inc	XOLREMDI	mavorixafor	83296-100	SODIUM LAURYL SULFATE	2031-04-26
X4 Pharmaceuticals Inc	XOLREMDI	mavorixafor	83296-100	SODIUM STEARYL FUMARATE	2031-04-26
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for MAVORIXAFOR

Excipient focus: CELLULOSE, MICROCRYSTALLINE

MAVORIXAFOR drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
X4 Pharmaceuticals Inc	mavorixafor	83296-100
>Company	>Ingredient	>NDC

MAVORIXAFOR drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

MAVORIXAFOR drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
X4 Pharmaceuticals Inc	mavorixafor	83296-100
>Company	>Ingredient	>NDC

MAVORIXAFOR drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

MAVORIXAFOR drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
X4 Pharmaceuticals Inc	mavorixafor	83296-100
>Company	>Ingredient	>NDC

MAVORIXAFOR drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

MAVORIXAFOR drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
X4 Pharmaceuticals Inc	mavorixafor	83296-100
>Company	>Ingredient	>NDC

MAVORIXAFOR drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM LAURYL SULFATE

MAVORIXAFOR drug variants containing SODIUM LAURYL SULFATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
X4 Pharmaceuticals Inc	mavorixafor	83296-100
>Company	>Ingredient	>NDC

MAVORIXAFOR drug variants not containing SODIUM LAURYL SULFATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STEARYL FUMARATE

MAVORIXAFOR drug variants containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
X4 Pharmaceuticals Inc	mavorixafor	83296-100
>Company	>Ingredient	>NDC

MAVORIXAFOR drug variants not containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.